Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countriesJanet M Raboud
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
BMC Infect Dis 10:40. 2010
....
A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophyJanet M Raboud
University of Toronto, Toronto, Canada
HIV Clin Trials 11:39-50. 2010
..To determine the impact of thiazolidinediones (TZD) on changes in limb fat mass in HIV-infected individuals, particularly in those not receiving a thymidine analogue...
- Once daily dosing improves adherence to antiretroviral therapy
Janet Raboud
Division of Infectious Disease, University Health Network, Toronto, ON, Canada
AIDS Behav 15:1397-409. 2011
..Other independent correlates of suboptimal adherence were younger age, lower positive social interaction and increased frequency of consuming > 6 alcoholic drinks on one occasion...
- Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy
Janet Raboud
University Health Network, Toronto, Ontario, Canada
HIV Clin Trials 11:340-50. 2010
..To determine the effects of gender and calendar year on time to and duration of virologic suppression among HIV-infected antiretroviral-naïve individuals initiating combination antiretroviral therapy (cART)...
- Association of vitamin D related information from a telephone interview with 25-hydroxyvitamin D
Harleen Sahota
Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray Street, Toronto, Ontario, Canada
Cancer Epidemiol Biomarkers Prev 17:232-8. 2008
..0006). The R(2) was 0.29 for the summer model and was 0.21 for the winter model. Overall, there was evidence to suggest that questions designed to assess vitamin D exposure were in fact related to serum 25(OH)D...
- Four-year follow-up of polyalkylimide gel use for the treatment of HIV-associated lipoatrophy
Mona R Loutfy
Maple Leaf Medical Clinic, Toronto, Ontario, Canada
HIV Clin Trials 12:323-32. 2011
..To evaluate polyalkylamide gel (PAIG) use in treating HIV-associated facial lipoatrophy (FLA) 4 years after its injection in an open-label, randomized controlled trial (RCT)...
- Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada
Nisha Andany
Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
HIV Clin Trials 12:89-103. 2011
..This study assessed ethnicity and gender differences in prevalence, type, and severity of antiretroviral-associated lipodystrophy in HIV-positive individuals in Ontario...
- Vitamin D association with estradiol and progesterone in young women
Julia A Knight
Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
Cancer Causes Control 21:479-83. 2010
..We conducted a study to determine whether there is an association between circulating 25-hydroxyvitamin D (25(OH)D) and estradiol and progesterone in young women...
- Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer
Kristina M Blackmore
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray Street, Box 18, Toronto, Ontario, Canada M5T3L9
Am J Epidemiol 168:915-24. 2008
..51, 1.22) tumors. This study suggests that vitamin D is associated with a reduced risk of breast cancer regardless of ER/PR status of the tumor. Future studies with a larger number of receptor-negative and mixed tumors are required...
- Immunologic Effectiveness of Maraviroc- and Raltegravir-Containing Regimens (R+M+) versus Raltegravir-Based Regimens That Do Not Include Maraviroc (R+M-)
Tony Antoniou
1University of Toronto, Toronto, Ontario, Canada
J Int Assoc Physicians AIDS Care (Chic) 11:192-7. 2012
..Objective: To compare the immunologic effectiveness of raltegravir-maraviroc (R+M+)-based regimens with raltegravir-based regimens that do not include maraviroc (R+M-) in treatment-experienced patients in clinical practice...
- Persistent HIV RNA shedding in semen despite effective antiretroviral therapy
Prameet M Sheth
Department of Medicine, Dalla Lana School of Public Health, Toronto, Ontario, Canada
AIDS 23:2050-4. 2009
..Isolates were drug-sensitive, and this phenomenon was not associated with semen drug levels or regimen...
- Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional study
Mona R Loutfy
Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
PLoS ONE 4:e7925. 2009
..In order to clarify the demand, and aid with appropriate health services planning for this population, our study aims to assess the fertility desires and intentions of HIV-positive women of reproductive age living in Ontario, Canada...
- Gender and ethnicity differences in HIV-related stigma experienced by people living with HIV in Ontario, Canada
Mona R Loutfy
Department of Medicine, Women s College Research Institute, Women s College Hospital, Toronto, Ontario, Canada
PLoS ONE 7:e48168. 2012
..Findings suggest differing approaches may be required to address HIV-related stigma based on gender and ethnicity; and such strategies should challenge racist and sexist stereotypes...
- No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults
Darrell Hs Tan
University Health Network Division of Infectious Diseases, Canada bUniversity of Toronto, Ontario, Canada
AIDS 25:207-10. 2011
..to determine the impact of oral tenofovir as part of combination antiretroviral therapy on asymptomatic herpes simplex virus (HSV) shedding...
Nonfinancial factors associated with decreased plasma viral load testing in Ontario, CanadaJanet M Raboud
Division of Infectious Diseases, University Health Network, University of Toronto, Ontario, Canada
J Acquir Immune Defic Syndr 39:327-32. 2005
..To examine whether individual characteristics were associated with differential use of viral load testing when testing is available without charge to all HIV-positive patients with provincial health insurance...
- Desires, Need, Perceptions, and Knowledge of Assisted Reproductive Technologies of HIV-Positive Women of Reproductive Age in Ontario, Canada
Yimeng Zhang
Women and HIV Research Program, Women s College Research Institute, Women s College Hospital, Toronto, ON, Canada M5G 1N6
ISRN Obstet Gynecol 2012:853503. 2012
..Fertility service professionals need to be aware of the increasing demand for ART among WLWHIV...
- Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial
Darrell H S Tan
University Health Network, 585 University Ave, 13N 1323, Toronto, Ontario, M5G 2N2 Canada
Trials 11:113. 2010
..Suppression of herpes simplex virus type 2 (HSV-2) may be a novel strategy for achieving this goal because HSV-2 is associated with clinically significant increases in HIV viral load, the primary driver of HIV disease progression...
- Light and exercise and melatonin production in women
Julia A Knight
Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
Am J Epidemiol 162:1114-22. 2005
..It is possible that the protective effect of exercise with respect to breast cancer may operate in part through an effect on melatonin...
- Vitamin D and reduced risk of breast cancer: a population-based case-control study
Julia A Knight
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray Street, Box 18, Toronto, Ontario, Canada M5T 3L9
Cancer Epidemiol Biomarkers Prev 16:422-9. 2007
..We conducted a population-based case-control study to assess the evidence for a relationship between sources of vitamin D and breast cancer risk...
- Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients
Mona R Loutfy
Maple Leaf Medical Clinic, 70 Carlton Street, Toronto, Ontario, Canada
AIDS 21:1147-55. 2007
..To evaluate the safety and efficacy of polyalkylimide gel (PAIG) in the treatment of HIV-associated facial lipoatrophy...
- Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy
Leah Szadkowski
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
AIDS Res Hum Retroviruses 28:1579-83. 2012
..Further studies should investigate adherence, comorbidities, and regimen changes in addition to the current covariates...
- Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients
Janet M Raboud
Department of Public Health Sciences and Division of Infectious Diseases, University Health Network, University of Toronto, Toronto, Ontario, Canada
AIDS 16:1627-32. 2002
..Given their high risk of short-term virological failure, patients who present with consecutive detectable pVL measurements following complete suppression should be considered ideal candidates for intervention studies...
